Remove Labelling Remove Packaging Remove Pharmacy Management
article thumbnail

PillPack from Amazon Pharmacy Expands to Medicare Part D: How PillPack and 24/7 Support Are Transforming Medication Access and Adherence

Pharmacy Times

What we've done is blend PillPack's innovative packaging with Amazon Pharmacy's user-friendly approach and affordability, so these patients can now get their medications in convenient, personalized packets and order everything online through our digital pharmacy.

article thumbnail

To Combat Medication Errors, Proper Pharmacy Inventory Counts Are Essential

Pharmacy Times

Detect-A-Dose lid-label cover enhances medication recognition, reducing packaging errors through a contrasting visual pattern. Pharmacies have vast and specialized product inventories that require special attention and comprehensive internal controls to increase efficiency and safeguard medicines. Image Credit: © Medi-Dose, Inc.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Lorundrostat Shows Clinically Meaningful Outcomes in Patients With CKD and Hypertension

Pharmacy Times

Along with the successful pivotal trials, Launch-HTN and Advance-HTN, and the ongoing open-label extension trial, these results comprise the core package for our planned NDA submission.” Explore-CKD established that lorundrostat 25 mg once daily has a favorable clinical profile for this patient population.

article thumbnail

Expanding Access: Digital Therapeutics and the Evolving Role of Pharmacists

Pharmacy Times

It's cognitive behavioral therapy packaged as a digital experience. I've even seen VR experiences, so it can be packaged in any type of digital experience. Pharmacy Times : What would the passage of the Access to Prescription Digital Therapeutics Act mean for the growth of PDTs?

article thumbnail

FDA Approves Tablet Formulation of Zanubrutinib for All Indications

Pharmacy Times

1,2 Image Credit: © stockdevil - stock.adobe.com Results from 2 single-dose, open-label, randomized phase 1 crossover studies of healthy adults served as the basis for this approval. Package insert. These trials were designed to establish bioequivalence between zanubrutinib capsules and zanubrutinib tablets. News Release.